New sensor could revolutionize blood sugar monitoring in intensive care
NCT ID NCT07448805
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
Researchers in Slovenia are testing a new continuous glucose monitor called Syai Tag in 100 intensive care patients. The device uses small sensors on the upper arm to track blood sugar levels without needles. The study will compare its accuracy to standard blood tests to see if it can safely replace frequent finger sticks or arterial line draws.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- continuous glucose monitor (device)
- What this could lead to
- If accurate, this device could provide reliable, painless glucose monitoring for critically ill patients, reducing the need for frequent blood draws.
- What could go wrong
- This is an early-stage accuracy study, not a treatment trial. The device may not be as accurate as standard methods, and results may not apply to all ICU patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD SUGAR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UMC Maribor
RECRUITINGMaribor, 2000, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- FitBit coaching may help amputees walk more after surgery
- Can brain waves predict thinking problems after sepsis?
- Can AI catch the leading cause of blindness before It's too late?
- Can tailored nutrition boost recovery in the ICU?